GlassScriptPhysician profile
Christine E Peck
NPI 1609101047
$2,885.07
in general payments reported to CMS, 2019-2025
24 companies · $767 in 2025
The $767 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $294 · 2023: $846 · 2024: $878 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,291 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,290.69 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $562.95 | 2022-2025 | |
| Glaxosmithkline, LLC. | $308.71 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $300.88 | 2023-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $260.47 | 2021-2025 | Tezspire, Airsupra, Wainua |
| Regeneron Healthcare Solutions, INC. | $206.47 | 2022-2025 | Dupixent |
| Amgen INC. | $188.20 | 2022-2024 | Tezspire, Tavneos |
| Astellas Pharma US INC | $139.60 | 2021-2025 | Cresemba |
| Grifols USA, LLC | $123.59 | 2022-2025 | Prolastin-C Liquid |
| Philips North America LLC | $105.64 | 2023-2025 | (Ak6) Vest Therapy, Reusable Vest |
| Axsome Therapeutics, INC. | $91.54 | 2023-2025 | Sunosi |
| Harmony Biosciences LLC | $77.88 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $70.81 | 2024-2025 | Uptravi, Opsumit |
| Verona Pharma, INC. | $58.36 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $54.00 | 2023-2024 | Inspire |
| Merck Sharp & Dohme LLC | $44.51 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $43.67 | 2024 | Glassia |
| Pulmonx Corporation | $41.52 | 2022 | |
| Pfizer INC. | $39.66 | 2021-2023 | |
| 3b Medical, INC. | $38.54 | 2025 | Luna |
| Alk-Abello, INC | $35.43 | 2024 | Ragwitek, Odactra, Grastek |
| Inogen, INC. | $29.90 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Zimmer Biomet Holdings, INC. | $25.79 | 2021 | |
| Mylan Specialty L.P. | $20.64 | 2022 | |
| Viatris Specialty LLC | $16.31 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Peck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.